Stretching the hope to live a long life than anticipated for patients having brain cancer, a group of researchers discovered a molecule, which is capable of inducing death of brain cancer cells.

The statement has been made by the journal PLoS One.

According to the Institute of Biomedical Research of Bellvitge, Catalonia, in Spain, the newly found molecule Nutlin-3 actuates a protein known as p53, which destroys the cells and prevents the return of glioblastoma multiforme, the most common and most aggressive category of primary brain tumour among human beings.

In spite of existing cures to discontinue it in addition to advancement in neurosurgery, radiotherapy and clinical experiments of therapeutic factors, the majority of patients expire within two years of diagnosis.

Researchers, with this novel finding, hope to perk up the treatment of glioblastoma and augment years of survival of sufferers.

With therapy based on the Nutlin-3a, it may be possible that cancer cells do not have the capability to recuperate after radiation therapy. (With Inputs from Agencies)